These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 19614820)

  • 1. Natural killer cell-based immunotherapy in cancer: current insights and future prospects.
    Sutlu T; Alici E
    J Intern Med; 2009 Aug; 266(2):154-81. PubMed ID: 19614820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for the use of NK cells in immunotherapy of human cancer.
    Ljunggren HG; Malmberg KJ
    Nat Rev Immunol; 2007 May; 7(5):329-39. PubMed ID: 17438573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo expansion of the highly cytotoxic human natural killer-92 cell-line under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy.
    Tam YK; Martinson JA; Doligosa K; Klingemann HG
    Cytotherapy; 2003; 5(3):259-72. PubMed ID: 12850795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections.
    Terunuma H; Deng X; Dewan Z; Fujimoto S; Yamamoto N
    Int Rev Immunol; 2008; 27(3):93-110. PubMed ID: 18437601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [NK cell-based immunotherapy: new prospects and involvement of dendritic cells].
    Borg C; Taieb J; Terme M; Maruyama K; Flament C; Angevin E; Zitvogel L
    Bull Cancer; 2003; 90(8-9):699-705. PubMed ID: 14609759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical applications of adoptive natural killer cell immunotherapy for cancer: current status and future prospects.
    Guo H; Qian X
    Onkologie; 2010; 33(7):389-95. PubMed ID: 20631487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cell-based immunotherapeutic strategies.
    Klingemann HG
    Cytotherapy; 2005; 7(1):16-22. PubMed ID: 16040380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Near-infrared emitting fluorescent nanocrystals-labeled natural killer cells as a platform technology for the optical imaging of immunotherapeutic cells-based cancer therapy.
    Lim YT; Cho MY; Noh YW; Chung JW; Chung BH
    Nanotechnology; 2009 Nov; 20(47):475102. PubMed ID: 19875875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK cell-based cancer immunotherapy.
    Stagg J; Smyth MJ
    Drug News Perspect; 2007 Apr; 20(3):155-63. PubMed ID: 17520092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Potential role of NK cells in future anti-tumor immunotherapies].
    Iannello A; Débbeche O; Samarani S; Sabbagh S; Duval M; Ahmad A
    Med Sci (Paris); 2007 May; 23(5):502-8. PubMed ID: 17502066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of DNA into natural killer cells for immunotherapy.
    Schoenberg K; Trompeter HI; Uhrberg M
    Methods Mol Biol; 2008; 423():165-72. PubMed ID: 18370197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can NK cells be a therapeutic target in human cancer?
    Chan CJ; Andrews DM; Smyth MJ
    Eur J Immunol; 2008 Nov; 38(11):2964-8. PubMed ID: 18979512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro activation of NK cytotoxicity with IL-2.
    Ibayashi Y; Tokuda Y; Saks ER; Sarna GP; Golub SH
    Prog Clin Biol Res; 1987; 244():275-85. PubMed ID: 3498954
    [No Abstract]   [Full Text] [Related]  

  • 15. Should natural killer cells be expanded in vivo or ex vivo to maximize their therapeutic potential?
    Miller JS
    Cytotherapy; 2009; 11(3):259-60. PubMed ID: 19347766
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel approaches using natural killer cells in cancer therapy.
    Suck G
    Semin Cancer Biol; 2006 Oct; 16(5):412-8. PubMed ID: 16914327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy in the context of hematopoietic stem cell transplantation: the emerging role of natural killer cells and mesenchymal stromal cells.
    Lankester AC; Ball LM; Lang P; Handgretinger R
    Pediatr Clin North Am; 2010 Feb; 57(1):97-121. PubMed ID: 20307714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invariant natural killer T cells and immunotherapy of cancer.
    Molling JW; Moreno M; van der Vliet HJ; van den Eertwegh AJ; Scheper RJ; von Blomberg BM; Bontkes HJ
    Clin Immunol; 2008 Nov; 129(2):182-94. PubMed ID: 18783990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic approaches to acute leukemia in the elderly.
    Farag SS; Caligiuri MA
    Semin Hematol; 2006 Apr; 43(2):118-25. PubMed ID: 16616045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting the role of hyperthermia in natural killer cell mediated anti-tumor responses.
    Dayanc BE; Beachy SH; Ostberg JR; Repasky EA
    Int J Hyperthermia; 2008 Feb; 24(1):41-56. PubMed ID: 18214768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.